Does RP-HPLC of polypeptides affect biological
activity?
Biological activity of proteins depends
on tertiary structure and permanent disruption of tertiary structure usually
reduces biological activity. RP-HPLC may disrupt protein tertiary structure
because of hydrophobic solvents used for elution or because of the interaction
of the protein with the hydrophobic surface of the material. The amount
of biological activity lost depends on the stability of the protein and
on the elution conditions used. The loss of biological activity can be
minimized by proper post-chromatographic treatment. Small peptides and
very stable proteins are less likely to lose biological activity than large
enzymes. Some specific points to keep in mind are:
| Denaturation of proteins on hydrophobic surfaces
is kinetically slow. Reducing the residence time of the protein in the column generally reduces the loss of biological activity. |
|
| Some solvents are less likely to cause a loss of biological activity than others. Isopropanol is the best solvent for retaining biological activity. Ethanol and methanol are slightly worse and acetonitrile causes the greatest loss of biological activity. | |
| Stabilizing factors, such as enzyme cofactors, added to the chromatographic eluent, stabilize proteins and reduce the loss of biological activity. | |
| The most important factor in maintaining or regaining biological activity is post-column sample treatment. Dissolution of a collected protein in a stabilizing buffer often allows the protein to re-fold. An example is HIV protease (Table 1). | |
| Examples of biological activity after RP-HPLC | |
| Trypsin. Reversed phase chromatography has been used to purify trypsin for use in protein digestion. | |
| Poliovirus proteins. Poliovirus proteins purified by reverse phase chromatography were able to induce production of specific antibodies in rabbits, indicating a retention of biological activity. | |
| Dissolution
After lyophilization, dissolve residue at 5-15 mg/ml in 50 mM sodium acetate, pH 5.5, containing 8 M urea, 1mM EDTA and 2.5 mM dithiothreitol. Refolding Dilute with 9 volumes of 50 mM acetate, pH 5.5, containing 1 mM EDTA and 2.5 mM dithiothreitol, 10% glycerol, 5% ethylene glycol and 0.2% Non-idet P-40 at 40C. Result Specific activity = 1.0+-0.1 µmol substrate hydrolyzed per minute per mg of protein- compared to specific activity of 1.2 for enzyme expressed in E. coli. |
Table 1
Procedure used |
| Pollen Allergens. The main protein allergen of Parietaria judaica retained IgE-binding activity even after RP-HPLC purification because it eluted at, low acetonitrile concentration. | |
| HIV protease. HIV protease regained most of its biological activity after reverse phase chromatography and post chromatographic treatment to allow refolding (Table 1). |
Perhaps the most compelling evidence that biological activity is not inevitably lost during reversed-phase chromatography is the fact that several commercial bio-therapeutics use reversed-phase chromatography in the purification of the marketed product.
| Erythropoetin may be purified using reversed-phase chromatography as an integral part of the purification process. | |
| Leukine, a marketed polypeptide therapeutic, uses reversed-phase HPLC as an integral part of its purification procedure. | |
| Human recombinant insulin purification uses reversed-phase chromatography in its production. |
Conclusion
While the conditions of reversed-phase chromatography may cause some
loss of tertiary structure and biological activity, in most cases this
loss of biological activity may be moderated or eliminated by use of optimum
chromatographic conditions or by post-chromatographic treatment.